Antihypotensive agent disrupts the immune system in sepsis11 June 2020
Patients who go into shock caused by sepsis are treated with norepinephrine. Researchers from Radboudumc published results in today’s American Journal of Respiratory and Critical Care Medicine revealing that its use is not without drawbacks.
Sepsis-associated acute kidney injury: A randomized clinical trial15 November 2018
Peter Pickkers, theme Infectious diseases and global health, published in JAMA, that among patients who were critically ill with sepsis-associated acute kidney injury, human recombinant alkaline phosphatase compared with placebo did not significantly improve short-term kidney function.
Haloperidol does not prevent delirium or improve survival rates in ICU patients Large-scale study shows commonly used drug has no preventive effect21 February 2018
Prophylactic use of the drug haloperidol does not help to prevent delirium in intensive care patients or improve their chances of survival. Therefore, there is no reason anymore to administer the drug as a preventive measure to reduce the burden of delirium.